Recent successes of immunomodulatory approaches for the treatment of serious diseases such as cancer have generated a significant growth in efforts aimed at the discovery of novel therapeutics in this ...

Even before companies spend exorbitant amounts on clinical trials (most of which fail), they already have spent significant time and money identifying the best drug candidates for those trials.

Pharmaceutical companies amass huge libraries of chemical compounds they can test to see if one just might be capable of being developed into a new drug. But what if, even with millions of compounds, ...

Compound libraries form a foundational element of modern drug discovery—the process of identifying new chemical or biological compounds that can become safe and effective medicines. Compound libraries ...

Combinatorial chemistry has been widely adopted by the pharmaceutical industry in the past decade. However, owing to perceived “failures” with this technology, the pharmaceutical industry has been ...

Sanofi and AstraZeneca have struck a deal in which they will exchange 210,000 chemicals from their respective compound libraries. The goal is to enhance the diversity of each company’s collection, ...

DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into an agreement with ...

Critics of siloed Big Pharma R&D often point to the untapped potential of leading firms' compound libraries as evidence of the need for greater openness. Giving a wider pool of researchers with IT and ...

KIEV, Ukraine--(BUSINESS WIRE)--Enamine Ltd., a chemical company, producer of building blocks and screening libraries, announced today that it has signed a collaboration agreement with small molecule ...